These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26538628)

  • 1. Cancer Models and Real-world Data: Better Together.
    Kim JJ; Tosteson AN; Zauber AG; Sprague BL; Stout NK; Alagoz O; Trentham-Dietz A; Armstrong K; Pruitt SL; Rutter CM;
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.
    Beaber EF; Kim JJ; Schapira MM; Tosteson AN; Zauber AG; Geiger AM; Kamineni A; Weaver DL; Tiro JA;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv120. PubMed ID: 25957378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
    Onega T; Beaber EF; Sprague BL; Barlow WE; Haas JS; Tosteson AN; D Schnall M; Armstrong K; Schapira MM; Geller B; Weaver DL; Conant EF
    Cancer; 2014 Oct; 120(19):2955-64. PubMed ID: 24830599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice.
    Schapira MM; Sprague BL; Klabunde CN; Tosteson AN; Bitton A; Chen JS; Beaber EF; Onega T; MacLean CD; Harris K; Howe K; Pearson L; Feldman S; Brawarsky P; Haas JS;
    J Gen Intern Med; 2016 Oct; 31(10):1148-55. PubMed ID: 27251058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.
    Haas JS; Sprague BL; Klabunde CN; Tosteson AN; Chen JS; Bitton A; Beaber EF; Onega T; Kim JJ; MacLean CD; Harris K; Yamartino P; Howe K; Pearson L; Feldman S; Brawarsky P; Schapira MM;
    J Gen Intern Med; 2016 Jan; 31(1):52-9. PubMed ID: 26129780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
    Ulyte A; Wei W; Dressel H; Gruebner O; von Wyl V; Bähler C; Blozik E; Brüngger B; Schwenkglenks M
    PLoS One; 2020; 15(4):e0231409. PubMed ID: 32298325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis.
    Mannucci A; Zuppardo RA; Rosati R; Leo MD; Perea J; Cavestro GM
    World J Gastroenterol; 2019 Jun; 25(21):2565-2580. PubMed ID: 31210710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
    Armstrong K; Kim JJ; Halm EA; Ballard RM; Schnall MD
    Cancer; 2016 May; 122(9):1338-42. PubMed ID: 26929386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
    Lansdorp-Vogelaar I; Gulati R; Mariotto AB; Schechter CB; de Carvalho TM; Knudsen AB; van Ravesteyn NT; Heijnsdijk EA; Pabiniak C; van Ballegooijen M; Rutter CM; Kuntz KM; Feuer EJ; Etzioni R; de Koning HJ; Zauber AG; Mandelblatt JS
    Ann Intern Med; 2014 Jul; 161(2):104-12. PubMed ID: 25023249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.
    Meester RGS; Peterse EFP; Knudsen AB; de Weerdt AC; Chen JC; Lietz AP; Dwyer A; Ahnen DJ; Siegel RL; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2974-2985. PubMed ID: 29846942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
    Smith RA; Brooks D; Cokkinides V; Saslow D; Brawley OW
    CA Cancer J Clin; 2013; 63(2):88-105. PubMed ID: 23378235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
    Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
    BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium.
    Tiro JA; Kamineni A; Levin TR; Zheng Y; Schottinger JS; Rutter CM; Corley DA; Skinner CS; Chubak J; Doubeni CA; Halm EA; Gupta S; Wernli KJ; Klabunde C
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1147-58. PubMed ID: 24917182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.
    Smith RA; Cokkinides V; Brawley OW
    CA Cancer J Clin; 2009; 59(1):27-41. PubMed ID: 19147867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to cancer screening guidelines across Canadian provinces: an observational study.
    Strumpf EC; Chai Z; Kadiyala S
    BMC Cancer; 2010 Jun; 10():304. PubMed ID: 20565862
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.